Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Another raise hahaha

<< Previous

Bullboard Posts

Next >>

Comment by TimboBagginson Oct 29, 2024 9:33am

145 Views

Post# 36286520

RE:RE:RE:RE:RE:RE:RE:Another raise hahaha

TommyNickels wrote: If the FDA is okay with 75 or 78 patients then all.is well. But if not, this million raise means the study has no chance of completing in 2024. Not ideal.

last week you sold because of something Roger said 6 years ago. Since then, you keep coming up with other issues. For someone who had apparently done so much research it blows my mind that you bought with all the apparent issues TLT has.
If you're unhappy just leave, you're not getting our shares this close to the end.

<< Previous

Bullboard Posts

Next >>

Fobi AI responds to cease trade order, filing delay “disappointing”